Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Michael Zelasky"'
Autor:
Michael Zelasky, Michael W. Dunne, Karthik Akinapelli, Anita Das, Helen W. Boucher, Steven Aronin
Publikováno v:
Open Forum Infectious Diseases
Background Sulopenem is a broad-spectrum IV and oral penem antibiotic being developed for the treatment of infections caused by multidrug-resistant bacteria. Overall and Clinical Success in Patients with an Uncomplicated UTI at Test of Cure (TOC) and
Autor:
Dainis Krievins, Michael Zelasky, James Baldassarre, Philip Giordano, Sailaja Puttagunta, Michael W. Dunne
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Dalbavancin when delivered as a single 1500-mg infusion is noninferior to the same total dose given as a 2-dose regimen, removing the logistical constraints related to the second dose while improving compliance and patient convenience.
Backgroun
Backgroun
Autor:
James Baldasarra, Dainis Krievins, Michael W. Dunne, Philip Giordano, Sailaja Puttagunta, Michael Zelasky
Publikováno v:
Open Forum Infectious Diseases. 2
Autor:
Rob Roy MacGregor, Samuel A. Bozzette, David M. Parenti, Michael P. Dubé, Diane V. Havlir, Kent A. Sepkowitz, Donald N. Forthal, J. Allen McCutchan, Carol A. Kemper, A. Clinton White, Fred R. Sattler, Stephen D. Nightingale, Mallory D. Witt, Francesca J. Torriani, Michael W. Dunne, Sarah H. Cheeseman, Princy Kumar, Michael Zelasky
Publikováno v:
Clinical Infectious Diseases. 27:1369-1375
We compared the efficacy of a 400-mg once-weekly dosage versus a 200-mg daily dosage of fluconazole for the prevention of deep fungal infections in a multicenter, randomized, double-blind trial of 636 human immunodeficiency virus-infected patients to
Autor:
Michael W. Dunne, W. Jeffrey Fessel, Jonathan D. Berman, Leonid B. Heifets, Kenneth F. Wagner, Raymond T. Chung, Margan J. Zajdowicz, Mark R. Wallace, William Byrne, Daniel B. Craig, J. William Kelly, Michael Zelasky, Richard Williams, Scott F. Paparello, Gregory P. Melcher, Gordon M. Dickinson, Edward C Oldfield
Publikováno v:
Clinical Infectious Diseases. 26:611-619
We conducted a randomized, double-blind, placebo-controlled multicenter trial of azithromycin (1,200 mg once weekly) for the prevention of Mycobacterium avium complex (MAC) infection in patients with AIDS and a CD4 cell count of < 100/mm3. In an inte